Qube Research & Technologies (QRT)
CLDI icon

Qube Research & Technologies (QRT)’s Calidi Biotherapeutics CLDI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CLDI Stock Details CLDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5
Closed -$338 – 3903
2024
Q1 		$338 Sell
5
-18
-78% -$1.84K ﹤0.01% 4112
2023
Q4 		$4.16K Buy
+23
New +$6.17K ﹤0.01% 3742

Other funds holding CLDI

RWI
Red Wave Investments Dillsburg, Pennsylvania $335M AUM 15.13% 1-Year Est. Return
CI
CPR Investments Rochester, Michigan $130M AUM 29.56% 1-Year Est. Return
RCI
RS Crum Inc Newport Beach, California $517M AUM 16.68% 1-Year Est. Return
DIM
Delta Investment Management San Francisco, California $559M AUM 19.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CLDI Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Calidi Biotherapeutics (CLDI) in Q2 2024, closing a stake of 5 shares — an estimated $338 sold.

Qube Research & Technologies (QRT) first reported a position in CLDI in Q4 2023 and held it in 2 quarters. The position peaked at $4.16K in Q4 2023. 31 funds tracked by Wall St. Rank hold CLDI as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Calidi Biotherapeutics position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 5 Calidi Biotherapeutics shares in Q2 2024, an estimated $338.
  • Qube Research & Technologies (QRT) first reported a position in Calidi Biotherapeutics in Q4 2023 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Calidi Biotherapeutics position peaked at $4.16K in Q4 2023.
  • 31 funds tracked by Wall St. Rank held Calidi Biotherapeutics as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.